Ad is loading...
RPTIX
Price
$109.86
Change
-$2.17 (-1.94%)
Updated
Nov 15 closing price
TMCGX
Price
$15.13
Change
-$0.29 (-1.88%)
Updated
Nov 15 closing price
Ad is loading...

RPTIX vs TMCGX

Header iconRPTIX vs TMCGX Comparison
Open Charts RPTIX vs TMCGXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.86
Change-$2.17 (-1.94%)
VolumeN/A
CapitalizationN/A
Thrivent Mid Cap Growth S
Price$15.13
Change-$0.29 (-1.88%)
VolumeN/A
CapitalizationN/A
RPTIX vs TMCGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RPTIX vs. TMCGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongSell and TMCGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31B vs. TMCGX (35.1M). RPTIX pays higher dividends than TMCGX: RPTIX (0.18) vs TMCGX (0.00). RPTIX was incepted earlier than TMCGX: RPTIX (9 years) vs TMCGX (5 years). TMCGX is a more actively managed with annual turnover of: 42.00 vs. RPTIX (21.70). TMCGX has a lower initial minimum investment than RPTIX: TMCGX (2000) vs RPTIX (500000). TMCGX annual gain was more profitable for investors over the last year : 23.81 vs. RPTIX (14.29).
RPTIXTMCGXRPTIX / TMCGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years5 years-
Gain YTD9.58611.82681%
Front LoadN/AN/A-
Min. Initial Investment500000200025,000%
Min. Initial Investment IRAN/AN/A-
Net Assets31B35.1M88,319%
Annual Yield % from dividends0.180.00-
Returns for 1 year14.2923.8160%
Returns for 3 years-18.50-15.57119%
Returns for 5 years14.07N/A-
Returns for 10 yearsN/A-5.92-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPRT4.150.10
+2.47%
Westport Fuel Systems
ZETA17.580.21
+1.21%
Zeta Global Holdings Corp
OTEX28.83-0.11
-0.38%
Open Text Corp
CLNE2.65-0.21
-7.34%
Clean Energy Fuels Corp
APVO0.21-0.03
-12.45%
Aptevo Therapeutics